TOKUSHIMA, Japan--(BUSINESS WIRE)--Following the previous information on Jan. 5th. in 2024, we are excited to share our latest development status. A Phase I clinical dose-finding study of DFP-14927 in ...
PORTLAND, Ore.--(BUSINESS WIRE)--Sparrow Pharmaceuticals, a clinical-stage biopharmaceutical company that develops novel, targeted therapies to address unmet needs in both endocrinology and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback